Tag Archives: Australian patents

HAZEL MOIR. Evergreening of patents and the cost of pharmaceuticals.

A low standard for granting patents can mean lengthy delays generic medicine availability. In one case this is shown to have cost taxpayers almost $A3 billion extra in Pharmaceutical Benefits Scheme outlays. A solution is to grant patents only for … Continue reading

Posted in Health, Politics | Tagged , , , | Comments Off on HAZEL MOIR. Evergreening of patents and the cost of pharmaceuticals.

Hazel Moir and Deborah Gleeson. Evergreening and how big pharma keeps drug prices high.

Efforts by pharmaceutical companies to extend their patents cost taxpayers millions of dollars each year. In some cases they also mean people are subjected to unnecessary clinical trials. Big pharma makes big profits. Their useful new drugs are patented, protecting … Continue reading

Posted in Economy, Health, Politics | Tagged , , , , , | Comments Off on Hazel Moir and Deborah Gleeson. Evergreening and how big pharma keeps drug prices high.

Hazel Moir, How trade agreements are locking in a broken patent system.

Ten years on from the Australia-US Free Trade Agreement, Australia is entering another round of negotiations towards the new and controversial Trans-Pacific Partnership. In this Free Trade Scorecard series, we review Australian trade policy over the years and where we … Continue reading

Posted in Economy, Politics | Tagged , , , , , | Comments Off on Hazel Moir, How trade agreements are locking in a broken patent system.